Menu

BeyondSPX has rebranded as EveryTicker. We now operate at everyticker.com, reflecting our coverage across nearly all U.S. tickers. BeyondSPX has rebranded as EveryTicker.

Price Performance Heatmap

5Y Price (Market Cap Weighted)

All Stocks (1105)

Company Market Cap Price
OFIX Orthofix Medical Inc.
Core product category covering orthopedic implants and surgical devices, including spinal hardware.
$554.89M
$14.05
-2.43%
MYGN Myriad Genetics, Inc.
Laboratory testing and advisory services; Myriad operates clinical labs delivering diagnostic tests.
$550.82M
$5.92
-1.99%
KOPN Kopin Corporation
CR3 medical headset and defense medical imaging/biometric sensing align with Medical Devices & Biometrics.
$537.26M
$3.28
+10.81%
ZIMV ZimVie Inc.
Dental Equipment—ZimVie directly designs and sells dental hardware used in clinics (implants, imaging, CAD/CAM, etc.).
$530.23M
$18.99
CRMD CorMedix Inc.
DefenCath is an FDA-approved antimicrobial catheter-lock device marketed by CorMedix.
$506.12M
$6.77
-3.42%
CERS Cerus Corporation
Cerus' INTERCEPT Blood System is a medical device platform; primary product is a device used in transfusion safety.
$498.42M
$2.60
-5.11%
MLAB Mesa Laboratories, Inc.
Clinical Genomics hardware (MassARRAY) is diagnostic equipment used in regulated lab environments, fitting Diagnostic Equipment.
$487.92M
$88.86
+1.08%
ORGO Organogenesis Holdings Inc.
Core wound care device category covering Apligraf and Dermagraft, along with barrier products like PuraPly and FortiShield.
$480.79M
$3.79
-4.53%
KIDS OrthoPediatrics Corp.
Directly manufactures pediatric orthopedic implants and devices (plates, screws, growing rods, braces), the core product category for the company.
$460.10M
$18.37
-1.82%
MG Mistras Group, Inc.
MG provides Laboratory Testing & Advisory Services as part of its inspection and testing offerings.
$456.04M
$14.46
+0.98%
CYH Community Health Systems, Inc.
CYH directly provides hospital inpatient and outpatient care services through a network of hospitals and related facilities.
$448.38M
$3.20
-4.19%
BWAY BrainsWay Ltd.
Core product: BrainsWay's Deep TMS neuromodulation devices.
$437.98M
$23.18
+0.32%
ANGO AngioDynamics, Inc.
Core product category: vascular intervention devices, including Auryon, AlphaVac, and AngioVac.
$430.54M
$10.46
-5.00%
CLPT ClearPoint Neuro, Inc.
ClearPoint's core offerings include neurosurgical navigation hardware and related surgical equipment (e.g., ClearPoint system, Prism Laser Therapy, Velocity Alpha drill).
$416.46M
$14.65
+0.03%
RXST RxSight, Inc.
RxSight's core offering is the Light Adjustable Lens system and related ophthalmic devices used in premium cataract surgery, which fits Ophthalmology Devices.
$401.39M
$9.81
+0.26%
AHG Akso Health Group
Sale of medical devices and biometrics hardware.
$381.12M
$1.54
+0.65%
TLSI TriSalus Life Sciences, Inc.
TriNav and related systems are vascular intervention devices used for embolization and targeted drug delivery.
$370.02M
$7.32
+0.48%
SOPH SOPHiA GENETICS S.A.
Liquid Biopsy: MSK-ACCESS application and liquid biopsy analytics integrated into the platform.
$368.31M
$5.46
+5.81%
DCTH Delcath Systems, Inc.
The company sells medical device technology (hepatic delivery system) and related procedures.
$362.76M
$10.37
+1.52%
DDD 3D Systems Corporation
Offers dental equipment and dental 3D printing solutions (NextDent).
$353.98M
$2.76
+4.55%
BNR Burning Rock Biotech Limited
Burning Rock's brPROPHET MRD and MCED products are ctDNA-based diagnostics delivered as a liquid biopsy test.
$344.69M
$32.26
-3.18%
QTRX Quanterix Corporation
Quanterix directly manufactures and sells ultra-sensitive diagnostic instruments (Simoa platforms) used for biomarker detection in blood and other samples.
$343.85M
$7.39
-7.04%
AUNA Auna S.A.
AUNA operates hospitals and provides inpatient and outpatient care, i.e., hospital services.
$342.48M
$4.62
+0.65%
SGHT Sight Sciences, Inc.
Directly manufactures ophthalmic surgical devices (OMNI Surgical System, TearCare-related tools) used in eye care, i.e., ophthalmology devices.
$338.82M
$6.47
-1.97%
MTLS Materialise N.V.
Materialise's Mimics platform centers on medical imaging analysis and planning workflows.
$333.14M
$5.63
+0.81%
NVEC NVE Corporation
Medical devices & biometrics applications, including implantable sensors and collaboration with Abbott.
$330.52M
$68.32
+3.17%
SENS Senseonics Holdings, Inc.
Senseonics develops and markets implantable medical devices and biometric sensing technologies (Eversense CGM), fitting the Medical Devices & Biometrics investable theme.
$316.10M
$7.77
+6.88%
LFCR Lifecore Biomedical, Inc.
New 5-head aseptic isolator filler expands capacity for filling into prefilled syringes.
$304.35M
$8.23
+1.67%
SMLR Semler Scientific, Inc.
QuantaFlo is a diagnostic device used to measure arterial blood flow for PAD, directly constituting Diagnostic Equipment.
$300.98M
$20.34
+0.02%
SCPH scPharmaceuticals Inc.
Auto-Injector Devices reflect the SCP-111 autoinjector program for at-home administration.
$299.33M
$5.67
SPOK Spok Holdings, Inc.
GenA alphanumeric pager represents a medical device hardware line under Medical Devices & Biometrics.
$270.77M
$13.13
-0.76%
SY So-Young International Inc.
Wuhan Miracle Laser integration indicates the company uses/markets medical devices and biometrics in aesthetics.
$265.19M
$2.67
+0.94%
QSI Quantum-Si incorporated
The company manufactures diagnostic-grade hardware instruments (Platinum/Proteus) used for proteomics analysis.
$257.17M
$1.28
+4.07%
HBB Hamilton Beach Brands Holding Company
Home health monitoring devices tied to HealthBeacon’s at-home patient monitoring platform and subscription model.
$256.32M
$19.69
-0.35%
KRMD KORU Medical Systems, Inc.
KRMD's core business is medical devices focused on patient-centric subcutaneous infusion systems (Freedom) and related components.
$254.75M
$5.52
-2.65%
NAUT Nautilus Biotechnology, Inc.
The hardware/assay suite functions as diagnostic-type equipment for proteomics analyses.
$252.61M
$2.00
+9.56%
MPAA Motorcar Parts of America, Inc.
MPAA markets and sells diagnostic equipment, such as the JBT-1 Bench Top tester.
$249.06M
$13.04
+1.36%
PROF Profound Medical Corp.
Profound's flagship TULSA-PRO is a surgical device used for MR-guided prostate tissue ablation.
$247.04M
$8.27
-0.84%
MGRM Monogram Orthopaedics, Inc.
Direct product category: Monogram's system is a surgical device used in operating rooms for orthopedic procedures.
$243.79M
$6.00
STXS Stereotaxis, Inc.
Catheter-based cardiology devices (ablation/catheters) are a core direct product, fitting Cardiology Devices.
$242.95M
$2.67
-4.12%
OWLT Owlet, Inc.
Owlet sells FDA-cleared Medical Devices & Biometrics (Dream Sock and BabySat) with wearable biosensing capabilities.
$234.19M
$13.73
+0.99%
← Previous
1 ... 4 5 6 7 8 ... 12
Next →
Showing page 6 of 12 (1105 total stocks)

Loading company comparison...

Loading research report...

SGHT Sight Sciences, Inc.

Sight Sciences Reports Q4 2025 Earnings: Revenue Up 7% to $20.4 M, Full‑Year Revenue Down 3% to $77.4 M

Jan 13, 2026
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Reports Q4 2025 Results, Sets 2026 Guidance and Announces CEO Transition

Jan 13, 2026
BWAY BrainsWay Ltd.

BrainsWay Secures FDA Approval for Neurolief’s At‑Home Depression Device, Expanding Its Treatment Portfolio

Jan 12, 2026
CERS Cerus Corporation

Cerus Reports Q4 2025 Product Revenue Growth, Projects 2026 Revenue Expansion

Jan 12, 2026
CLPT ClearPoint Neuro, Inc.

ClearPoint Neuro Reports 20% Comparable Sales Growth in Q4 2025, Revenue $10.4 Million

Jan 12, 2026
KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp. Reports Record 2025 Revenue, Guides 2026 Growth

Jan 12, 2026
KRMD KORU Medical Systems, Inc.

KORU Medical Reports Strong Q4 2025 Earnings, Highlights Oncology Expansion

Jan 12, 2026
DCTH Delcath Systems, Inc.

Delcath Systems Reports Preliminary Q4 and Full‑Year 2025 Financial Results, Exceeding Expectations

Jan 09, 2026
QTRX Quanterix Corporation

Quanterix Names Everett Cunningham as President and CEO, Effective Jan. 19

Jan 09, 2026
SENS Senseonics Holdings, Inc.

Senseonics and Sequel MedTech Announce First Commercial Patients Using Eversense 365 with twiist AID System

Jan 09, 2026
CRMD CorMedix Inc.

CorMedix Reports Strong Q4 2025 Results, Sets Lower 2026 Revenue Guidance

Jan 08, 2026
SOPH SOPHiA GENETICS S.A.

SOPHiA GENETICS Announces Strategic Collaboration with MD Anderson Cancer Center to Accelerate AI‑Driven Precision Oncology

Jan 08, 2026
ANGO AngioDynamics, Inc.

AngioDynamics CEO Jim Clemmer Announces Retirement, Company Reports Strong Q2 FY2026 Earnings

Jan 07, 2026
BWAY BrainsWay Ltd.

BrainsWay Secures First Payer Coverage for Accelerated SWIFT Deep TMS Protocol

Jan 07, 2026
ANGO AngioDynamics, Inc.

AngioDynamics Reports Strong Q2 FY2026 Earnings, Beats Revenue and EPS Estimates, Raises Guidance

Jan 06, 2026
PROF Profound Medical Corp.

Profound Medical’s TULSA‑PRO Debuts in Commercial Use at Johns Hopkins, Signaling Expansion of Prostate Cancer Treatment

Jan 06, 2026
DCTH Delcath Systems, Inc.

Delcath Systems Publishes Subgroup Analyses of Phase 3 FOCUS Study

Jan 01, 2026
KRMD KORU Medical Systems, Inc.

KORU Medical Files 510(k) for FreedomEDGE System to Deliver Oncology Biologic

Dec 31, 2025
PROF Profound Medical Corp.

Profound Medical Corp. Upsizes Private Placement to Raise $6.45 Million for TULSA‑PRO Commercialization

Dec 26, 2025
RXST RxSight, Inc.

RxSight Names New CFO as Shelley Thunen Transitions

Dec 23, 2025
BWAY BrainsWay Ltd.

Optum Expands Coverage of BrainsWay’s Deep TMS for Adolescents, Adding 180 Million Covered Lives

Dec 22, 2025